DD-2

N/A

Report date: 2023/12/22 10:28:16
NME

Base Information

Drug NameDD-2
Drug Alias NameDD-2
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionPolo like kinase 1 degraders
TargetsPolo like kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Basic Science InstituteDandicure Inc
China Registration ClassN/A

Develop Information

Active CompaniesDandicure IncKorea Basic Science Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A